- Home
- PRME vs CTRN Comparison
PRME vs CTRN Comparison
Compare PRME & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | CTRN |
|---|---|---|
| Founded | 2019 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.0M | 559.1M |
| IPO Year | 2022 | 2005 |
Fundamental Metrics
Financial Performance| Metric | PRME | CTRN |
|---|---|---|
| Price | $4.67 | $45.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $7.30 | ★ $91.00 |
| AVG Volume (30 Days) | ★ 5.4M | 161.9K |
| Earning Date | 11-17-2026 | 12-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.18 | ★ 112.14 |
| EPS | N/A | ★ 0.80 |
| Revenue | $4,632,000.00 | ★ $819,962,000.00 |
| Revenue This Year | $90.65 | $10.94 |
| Revenue Next Year | $19.47 | $8.69 |
| P/E Ratio | ★ N/A | $72.23 |
| Revenue Growth | ★ 55.28 | 8.88 |
| 52 Week Low | $2.67 | $36.05 |
| 52 Week High | $5.91 | $77.91 |
Technical Indicators
Market Signals| Indicator | PRME | CTRN |
|---|---|---|
| Relative Strength Index (RSI) | 56.51 | 42.46 |
| Support Level | $2.94 | $42.53 |
| Resistance Level | $4.80 | $47.74 |
| Average True Range (ATR) | 0.50 | 3.61 |
| MACD | 0.03 | 0.79 |
| Stochastic Oscillator | 47.02 | 11.36 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.
About CTRN Citi Trends Inc.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.